Plasma separation for artificial liver support.
A bioartificial liver (BAL) support system, using plasma separation, has been developed to support acute liver failure patients. This study examined 14 consecutive BAL treatments in nine patients with severe acute liver failure. We report methods to achieve and manage plasma separation for an extended period of time. The mean duration of a BAL treatment was 435 minutes, with 26-59 liters of blood processed. Ionized hypocalcemia resulting in muscle twitching was a side effect of the therapy. Ionized calcium levels decreased significantly (P < .02) after BAL treatment; however, total calcium levels increased (P < .05). No significant changes were noted in heart rate, electrocardiogram [Q-T (Q-Tc) interval], blood pressure, prothrombin time, partial thromboplastin time, hematocrit, platelet count and serum phosphorous, magnesium, glucose, and pH. Plasma fibrinogen levels decreased significantly (P < .002). Ionized hypocalcemia due to the chelating effect of sodium citrate was controlled by calcium chloride administration, adjustment of blood separation rates, and reduction of the blood-to-citrate ratio. This report demonstrates that intensive, large-volume plasma separation for long periods of time can be achieved safely in critically ill patients without serious adverse effects.
LePage
E B
EB
Liver Support Unit, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Lane
R
R
McKay
D
D
Rozga
J
J
Demetriou
A A
AA
D000293:Adolescent; D000328:Adult; D000368:Aged; D001187:Artificial Organs; D002118:Calcium / Q000097:blood; D002648:Child; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008099:Liver / Q000502:physiology*; D017114:Liver Failure, Acute / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010951:Plasma Exchange
D002118:Calcium